Notably, bioinformatics and tissue arrays analysis demonstrated that decreased YTHDC2 was highly associated with smoking history, pathological stage, invasion depth, lymph node metastasis and poor outcomes. Here, YTHDC2 is linked to metastatic malignant neoplasm in the lymph nodes.